Novel RNAi therapeutic targeting INHBE aims to address obesity and associated cardiometabolic disorders Suzhou Ribo Life ...

CellFiber, a biotechnology company specialising in cell and gene therapy technologies, has announced the official launch of ...

Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, and Innovita Biological Technology Co., ...

OB-001 is a highly selective and effective inhibitor of two key efflux pumps (P-gp and BCRP), which are present both on the ...

Company plans to initiate clinical development of tonabersat in 2027, exploring a potential non-invasive treatment option for ...

Energenesis Biomedical Co., Ltd. (TWSE: 6657) today announced that it has signed a Memorandum of Understanding ("MOU") with ...

EpiSign Inc. and Geneyx Genomex Ltd. announced a partnership to advance the integration of genomic and epigenomic analysis ...

Closed-loop platform integrates generative AI, biological modelling and automated experiments as XtalPi advances six ...

Figure 1. The 18A queue by month of latest Application Proof, coloured by the modality of each applicant's lead asset. Solid ...

QIAGEN N.V. announced new artificial intelligence (AI) capabilities to help researchers analyze complex biological and ...

Abogen Biosciences ("Abogen" or the "Group"), a clinical-stage biotechnology group pioneering RNA innovation, announced that ...

Lonza, the world's leading contract development and manufacturing organization (CDMO), and Asimov, the company building an AI ...